Truist Financial Corp Astrazeneca PLC Transaction History

Truist Financial Corp

  • $62.7 Billion
  • Q4 2024

A detailed history of Truist Financial Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Truist Financial Corp holds 243,923 shares of AZN stock, worth $17.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
243,923
Previous 256,440 4.88%
Holding current value
$17.6 Million
Previous $20 Million 20.02%
% of portfolio
0.03%
Previous 0.03%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025
SELL
$63.2 - $79.58 $791,074 - $996,102
-12,517 Reduced 4.88%
243,923 $16 Million
Q3 2024

Nov 13, 2024
BUY
$76.67 - $87.62 $457,106 - $522,390
5,962 Added 2.38%
256,440 $20 Million
Q2 2024

Aug 20, 2024
BUY
$66.81 - $80.83 $739,853 - $895,111
11,074 Added 4.63%
250,478 $19.5 Million
Q1 2024

May 10, 2024
SELL
$61.03 - $69.57 $261,574 - $298,177
-4,286 Reduced 1.76%
239,404 $16.2 Million
Q4 2023

Feb 02, 2024
BUY
$61.89 - $69.28 $327,336 - $366,421
5,289 Added 2.22%
243,690 $16.4 Million
Q3 2023

Nov 14, 2023
SELL
$64.85 - $71.7 $575,089 - $635,835
-8,868 Reduced 3.59%
238,401 $16.1 Million
Q2 2023

Aug 01, 2023
BUY
$69.91 - $75.81 $471,263 - $511,035
6,741 Added 2.8%
247,269 $17.7 Million
Q1 2023

May 05, 2023
BUY
$63.15 - $71.6 $191,155 - $216,733
3,027 Added 1.27%
240,528 $16.7 Million
Q4 2022

Feb 17, 2023
SELL
$54.21 - $70.44 $1.46 Million - $1.9 Million
-27,006 Reduced 10.21%
237,501 $16.1 Million
Q3 2022

Oct 26, 2022
BUY
$53.02 - $135.75 $1.52 Million - $3.89 Million
28,690 Added 12.17%
264,507 $14.5 Million
Q2 2022

Jul 22, 2022
BUY
$59.26 - $71.14 $580,570 - $696,958
9,797 Added 4.33%
235,817 $15.6 Million
Q1 2022

Apr 22, 2022
BUY
$55.72 - $67.12 $1.33 Million - $1.6 Million
23,813 Added 11.78%
226,020 $15 Million
Q4 2021

Feb 14, 2022
BUY
$54.02 - $63.83 $2.61 Million - $3.08 Million
48,330 Added 31.41%
202,207 $11.8 Million
Q3 2021

Nov 05, 2021
BUY
$55.56 - $60.79 $1.11 Million - $1.22 Million
20,025 Added 14.96%
153,877 $9.24 Million
Q2 2021

Aug 16, 2021
SELL
$48.42 - $60.18 $126,908 - $157,731
-2,621 Reduced 1.92%
133,852 $8.02 Million
Q1 2021

May 17, 2021
SELL
$47.16 - $54.44 $779,224 - $899,512
-16,523 Reduced 10.8%
136,473 $6.79 Million
Q4 2020

Feb 18, 2021
SELL
$48.52 - $58.02 $2.58 Million - $3.09 Million
-53,227 Reduced 25.81%
152,996 $7.65 Million
Q3 2020

Nov 05, 2021
BUY
$53.07 - $61.1 $17,778 - $20,468
335 Added 0.16%
206,223 $11.3 Million
Q3 2020

Nov 13, 2020
SELL
$53.07 - $61.1 $2.18 Million - $2.51 Million
-41,074 Reduced 16.63%
205,888 $11.3 Million
Q2 2020

Nov 16, 2021
BUY
$43.1 - $55.31 $14,438 - $18,528
335 Added 0.14%
246,962 $13.1 Million
Q2 2020

Aug 14, 2020
BUY
$43.1 - $55.31 $1.68 Million - $2.16 Million
39,011 Added 18.79%
246,627 $13 Million
Q1 2020

Nov 05, 2021
BUY
$37.79 - $51.33 $12,659 - $17,195
335 Added 0.16%
207,616 $9.27 Million
Q1 2020

May 15, 2020
SELL
$37.79 - $51.33 $2.24 Million - $3.04 Million
-59,293 Reduced 22.24%
207,281 $9.26 Million
Q4 2019

Nov 16, 2021
BUY
$42.46 - $50.46 $14,224 - $16,904
335 Added 0.13%
266,574 $13.3 Million
Q4 2019

Feb 14, 2020
BUY
$42.46 - $50.46 $8.29 Million - $9.86 Million
195,343 Added 275.53%
266,239 $13.3 Million
Q3 2019

Oct 31, 2019
SELL
$40.12 - $45.47 $465,191 - $527,224
-11,595 Reduced 14.06%
70,896 $3.16 Million
Q2 2019

Jul 24, 2019
SELL
$37.28 - $41.68 $649,044 - $725,648
-17,410 Reduced 17.43%
82,491 $3.41 Million
Q1 2019

Apr 23, 2019
SELL
$35.49 - $43.02 $1.11 Million - $1.34 Million
-31,260 Reduced 23.83%
99,901 $4.04 Million
Q4 2018

Jan 22, 2019
SELL
$36.86 - $41.49 $887,109 - $998,539
-24,067 Reduced 15.5%
131,161 $4.98 Million
Q3 2018

Oct 17, 2018
SELL
$34.76 - $39.72 $403,806 - $461,427
-11,617 Reduced 6.96%
155,228 $6.14 Million
Q2 2018

Jul 26, 2018
SELL
$34.55 - $37.05 $324,009 - $347,454
-9,378 Reduced 5.32%
166,845 $5.86 Million
Q1 2018

Apr 20, 2018
BUY
$32.97 - $36.63 $397,848 - $442,014
12,067 Added 7.35%
176,223 $6.16 Million
Q4 2017

Jan 29, 2018
BUY
$32.09 - $34.78 $380,426 - $412,316
11,855 Added 7.78%
164,156 $5.7 Million
Q3 2017

Oct 23, 2017
BUY
$28.96 - $34.0 $4.41 Million - $5.18 Million
152,301
152,301 $5.16 Million

Others Institutions Holding AZN

# of Institutions
1,350
Shares Held
477M
Call Options Held
5.39M
Put Options Held
3.75M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $223B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email